Penn Center for Engineering
Technologies
Sectors
PCI Home
SUBSCRIBE
← BACK TO SECTORS
LPNs For T Cell Engineering (Ex Vivo and In Vivo)
PENN TECHNOLOGIES
Cholesterol Analogues Incorporated Into LNPs For Enhanced mRNA Delivery
Lipid nanoparticle-based mRNA delivery for CAR T-cell engineering
PENN STARTUPS
Penn Researchers
Carl June
Hanwen Zhang
Margaret Billingsley
Michael Mitchell
Nathan Singh
Savan Patel
Xuexiang Han
Keywords
Inflammation
,
Immunoncology
,
Gene Therapy
,
Bioengineering
,
Genetic Disorders
,
Immunotherapy
,
COVID-19
,
Immunology
,
Drug Delivery
,
Cell Therapy